Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Orchestra BioMed Holdings, Inc. - Ordinary Shares
(NQ:
OBIO
)
4.390
-0.050 (-1.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
24,286
Open
4.393
Bid (Size)
1.780 (2)
Ask (Size)
4.800 (10)
Prev. Close
4.440
Today's Range
4.360 - 4.595
52wk Range
4.220 - 18.68
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q4 2023
March 27, 2024
OBIO stock results show that Orchestra BioMed Hldgs beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
March 27, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Performance
YTD
-50.00%
-50.00%
1 Month
-17.25%
-17.25%
3 Month
-40.03%
-40.03%
6 Month
-4.77%
-4.77%
1 Year
-71.53%
-71.53%
More News
Read More
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
March 26, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
March 13, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed to Participate in Upcoming Investor Conferences
March 07, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
March 06, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years
February 26, 2024
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update
November 13, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Top 4 Health Care Stocks That Should Keep You Up At Night
September 21, 2023
Via
Benzinga
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 20, 2023
Via
Benzinga
Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 19, 2023
Via
Benzinga
Why Shares of Orchestra BioMed Jumped Tuesday
September 19, 2023
Via
The Motley Fool
Exposures
Product Safety
Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet
September 19, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Orchestra BioMed, Vital Farms And Other Big Stocks Moving Higher On Tuesday
September 19, 2023
Via
Benzinga
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
September 19, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
September 15, 2023
Via
Benzinga
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 14, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 21, 2023
Via
Benzinga
Why Super League Gaming Are Trading Lower By Around 46%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 21, 2023
Via
Benzinga
Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update
August 10, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Orchestra BioMed™ Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon™ in Patients with Coronary In-Stent Restenosis
August 08, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 12, 2023
Via
Benzinga
Why Shares of Orchestra BioMed Holdings Jumped Wednesday
June 28, 2023
Via
The Motley Fool
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes
June 26, 2023
From
Orchestra BioMed Holdings, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.